BCL2L1 and breast carcinoma: In addition, we have shown that EphB4 upregulates several antiapoptotic proteins, particularly bcl-xl, in bladder and breast cancer cells (Kumar et al, 2006; Xia et al, 2006), thus suggesting other sites of action by which EphB4 may inhibit tumour cell apoptosis.